- Home
- COR
COR
Cencora Inc.
as 03-25-2025 12:31pm EST
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | CONSHOHOCKEN |
| Market Cap: | 49.1B | IPO Year: | N/A |
| Target Price: | $277.30 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 7.02 | EPS Growth: | -23.43 |
| 52 Week Low/High: | $214.77 - $271.08 | Next Earning Date: | 04-30-2025 |
| Revenue: | $303,192,826,000 | Revenue Growth: | 11.64% |
| Revenue Growth (this year): | 10.95% | Revenue Growth (next year): | 6.89% |
Stock Insider Trading Activity of Cencora Inc. (COR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mauch Robert P. | COR | President & CEO | Mar 18 '25 | Sell | $260.93 | 4,970 | $1,296,822.10 | 49,326 | |
| Krikorian Lazarus | COR | SVP & Chief Accounting Officer | Mar 10 '25 | Sell | $260.06 | 2,000 | $520,120.00 | 20,154 | |
| Mauch Robert P. | COR | President & CEO | Mar 3 '25 | Sell | $255.00 | 4,970 | $1,267,350.00 | 49,326 | |
| Walgreens Boots Alliance, Inc. | COR | 10% Owner | Feb 6 '25 | Sell | $244.51 | 1,286,376 | $314,531,795.76 | 18,898,115 |
Latest Cencora Inc. News
COR Breaking Stock News: Dive into COR Ticker-Specific Updates for Smart Investing
Argus Research
a day ago
Weekly Stock List
Zacks
7 days ago
Here is Why Growth Investors Should Buy Cencora (COR) Now
Investor's Business Daily
13 days ago
This Medical Services Stock Looks Relatively Healthy In A Sick Market
Zacks
13 days ago
Here's Why Cencora (COR) is a Strong Growth Stock
Simply Wall St.
14 days ago
Cencora (NYSE:COR) Eyes Acquisitions and Technology Investments with Potential OneOncology Buyout
Zacks
14 days ago
Here's Why Cencora (COR) is a Strong Value Stock
Zacks
14 days ago
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
Simply Wall St.
21 days ago
These 4 Measures Indicate That Cencora (NYSE:COR) Is Using Debt Reasonably Well
Compare COR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COR Cencora Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.